CHEN Jia-xin, SHEN Hong-hui, LIU Xiao-qiong, et al. Anti-HBV Effect and Mechanism of Sophora Alkaloids Combined with Entecavir[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(1): 107-113.
CHEN Jia-xin, SHEN Hong-hui, LIU Xiao-qiong, et al. Anti-HBV Effect and Mechanism of Sophora Alkaloids Combined with Entecavir[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(1): 107-113. DOI: 10.13422/j.cnki.syfjx.2017010107.
Objective: To investigate the anti-hepatitis B virus(HBV) effects of sophora alkaloids combined with entecavir
and observe its effect on p38 MAPK and sodium taurocholote cotransporting poly peptide(NTCP) expression levels. Method: Entecavir-resistant hepatitis HBV replication ell lines HepG2.A64 were used as the models
and then CPE and CCK-8 were used respectively to investigate the cytotoxicity in case of oxymatrine
matrine
sophoridine
sophocarpine or nucleoside drug entecavir as well as combined use of entecavir and any above sophora alkaloids. The levels of HbsAg
HBV DNA replication
p38 and NTCP mRNA expression
as well as p38 and p-p38 protein expression levels were detected by ELISA
Real-time PCR and Western blot. Result: As compared with medication alone
HBsAg secretion
HBV DNA replication were significantly inhibited 72 h after combined use of oxymatrine and entecavir
and NTCP expression levels and p38 phosphorylation levels were significantly reduced. Conclusion: The combined use of oxymatrine and entecavir could achieve the anti-HBV effect by down-regulating the expression of NTCP and inhibiting the phosphorylation of p38.The combined use of oxymatrine and entecavir could significantly increase anti-HBV effect.